IPSC - Century Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

51.63M

Cash

192M

Avg Qtr Burn

-22.34M

Short % of Float

7.59%

Insider Ownership

28.22%

Institutional Own.

53.67%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
CNTY-101 Details Cancer, Relapsed/ refractory lymphoma	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CNTY-101 Details Systemic lupus erythematosus	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.